Pharmacy Authorization & Exceptions Agent
Handles Part D coverage determinations, formulary and tiering exceptions, step-therapy overrides and medical-benefit drug authorizations against P&T-approved criteria.
Sorts the request onto the right rail first: the drug queue answers to a different rulebook than the medical one beside it. A Part B infusion under Medicare Advantage runs 72 hours standard with no extension; an exception starts counting only when the prescriber's supporting statement lands, backstopped at fourteen days after which the plan decides regardless. Refusing the drug takes a pharmacist; if the argument is about the underlying condition it takes a physician.
Authority
Approve within policy
Team role
Provides specialist analysis
Handoffs
Named collaborators
The role
What it owns and where its authority ends
Desk
Utilization Management & Prior Authorization
Desk workflow
Take the request on whatever channel it arrives, start the correct clock under the correct rulebook, assemble the clinical packet and rank the governing criteria, let the approvals that sit inside explicit criteria go out under licensed supervision, route everything else to a physician or appropriate clinical peer with the dossier and draft notice already built, then audit the whole path for any request that ended without one.
Collaboration
Moves work through defined stages
Decision boundary
Approves only inside a defined policy and escalation boundary.
Systems and capabilities involved
Surescripts and CoverMyMeds electronic prior authorization
The NCPDP SCRIPT rail from the prescriber's record; CMS-0057-F excludes drugs from its API requirements.
MHK coverage determination workflow
Formulary file and P&T-approved criteria
Part B versus Part D routing and clock calculator
Reviewing pharmacist
Handoffs
What this role gives and receives
Capabilities offered
The handoffs name the next owner or specialist and the work that moves between them.
Handoff to
Handoff to
Handoff to
Receives from
External handoff
Reviewing pharmacist
External handoff
P&T Committee
External handoff
Prescribing practitioner
External handoff
Pharmacy benefit manager
Context
What the role needs to do the work
- Current work
- Request classification, Part B or Part D routing, exception type, supporting-statement status, and the running clock with its backstop.
- Prior interactions
- Prior fills, prior trials of preferred agents, and earlier exception outcomes for this member and drug.
- Policies and reference
- Formulary and tier structure, P&T-approved criteria and step-therapy protocols, and the exception categories at 42 CFR 423.578.
- Working method
- Supporting-statement chase sequence and the step-therapy legality checklist.
Illustrative workflow
How the work moves
Starting point
A rheumatologist requests a formulary exception for a non-preferred biologic, and by day eleven the prescriber's supporting statement still has not arrived.
- 01
Classify it as a formulary exception rather than a tiering exception, and confirm the drug runs on the Part D clock rather than the Part B medical clock.
- 02
Chase the supporting statement through the electronic prior-authorization thread and by phone to the prescribing office, logging each attempt with name and timestamp.
- 03
Set the fourteen-day backstop so the determination issues within 72 hours of that window closing whether or not the statement arrives.
- 04
Compare the documented trials of preferred agents against the P&T-approved criteria and stage the finding with the gap named.
Result
Either an exception grant executed under the pharmacy supervisor's authority where the P&T criteria are explicitly met, or a non-approval packet for the reviewing pharmacist, who decides.
Checks and boundaries
What must be tested or reviewed
- 01Clock and routing test on a mixed corpus of injectables and infusions: Part B under Medicare Advantage runs 72 hours standard and 24 expedited with no extension available, Part D runs 72 and 24, and exceptions run from the supporting statement with the fourteen-day backstop; running a Part B drug on the seven-day medical clock is a hard failure.
- 02When the fourteen-day supporting-statement window closes, the determination still issues inside the following 72 or 24 hours, and no non-approval is recorded without a licensed pharmacist or physician having decided it.
- 03Exception-type discrimination across formulary, tiering (including specialty-tier carve-outs), quantity and dose-limit, and step-therapy override requests, scored on whether the correct prescriber supporting statement was requested for each.
- 04Step-therapy legality check on Medicare Advantage Part B protocols: a protocol applied to a continuing administration inside the 365-day lookback, or one lacking documented P&T approval, is refused with the rule it is refused under named.
Human authority
- A licensed pharmacist decides every pharmaceutical non-approval; a physician decides where the judgment is about the underlying condition rather than the drug.
- The P&T Committee owns the criteria and every step-therapy protocol this agent applies, and clears any change to them before it reaches the queue.
- The pharmacy supervisor holds the license under which criteria-met exception grants are executed.
Keep exploring